WW International, Inc. reported Q4 2022 revenues of $223.9 million and an operating loss of $50.8 million, primarily due to $57.6 million in non-cash intangible impairment charges. The company ended the year with 3.5 million subscribers, surpassing guidance. WW also announced an agreement to acquire Sequence, a digital health platform for clinical weight management.
Ended 2022 with 3.5 million subscribers, exceeding guidance.
Revenues for Q4 2022 were $223.9 million.
Operating loss of $50.8 million primarily due to non-cash intangible impairment charges.
Announced agreement to acquire Sequence, a digital health platform for clinical weight management.
WW International expects Q1 2023 revenues to be approximately $235.0 million and anticipates an operating loss in the range of ($30.0) million to ($35.0) million, which includes approximately $20.0 million in restructuring charges.
Analyze how earnings announcements historically affect stock price performance